Pinned Tweet
We leverage our life science and medical sector expertise to create communications impact – for your organization and patients in need
Let's make an impact together!
#Allele #Communications #LifeSciences #Media #SocialMedia #Science #DrugDiscovery #Patients #runboyrun
Has your company's investor relations (IR) program stalled or become less effective?
Growth rarely stops loudly. It flattens...
Majority of Traditional IR produces an elevated amount of activity that lasts a quarter or two. Then investor reach and capacity run out, and engagement levels off.
We built Quantum IR™ to address this fundamental issue.
Our proprietary technology platform targets, engages, nurtures and assist in converting high-intent investors across all investor profiles (Institutions, Family Offices, Registered Investment Advisors, Financial Advisors, High Net Worth, Retail, and Agentic) and Sell-side (Analysts, Investment Bankers and Equity Capital Markets).
This is all done in a bespoke, compliant, scalable and repeatable system with outcome reporting.
Is your current IR program doing the same?
#InvestorRelations #PublicCompanies #CapitalMarkets
26
The Allele Communications team came out in full force this past weekend for the Victory Over Cancer 5K!
We were thrilled to take part in this race for a great cause, and we can't wait to participate next year.
#V5k #VictoryOverCancer
1
96
Allele Communications retweeted
Press Release: ABVC Corporate Update and CEO's Letter to Shareholders
loom.ly/5kI-gS8
$ABVC #shareholders #investment #nasdaq #science #drugdevelopment #drugresearch
Allele Communications retweeted
Every week we go over the latest in Biotech news with our Biotech Weekly report
Read the full report here: loom.ly/XOFx8-c
#capitalmarkets #analytics #stocks #biotech #pharma #nasdaq #science #RandD #research
Allele Communications retweeted
Genelux Strengthens Leadership Team With Key New Hires.
Read more here: loom.ly/54LhGns
$GNLX #biotech #stage4needsmore
Allele Communications retweeted
Historical data in 4th line and beyond shows a median overall survival of only 9.8 months on a median fifth line of treatment, while Olvi-Vec Phase 2 patients achieved a mOS of 15.7 mos.
#stage4needsmore #drugdevelopment #biotech #finance
Allele Communications retweeted
This weeks Biotech Weekly report is out! Read the full report here: loom.ly/XOFx8-c
#capitalmarkets #analytics #stocks #biotech #pharma #nasdaq #science #RandD #research
Allele Communications retweeted
Check out 3 Allele clients on @BioPharmaDive most recent IPO's
Great to see Genelux standing out from the pack!
$GNLX $COYA $GDTC
#capitalmarkets #analytics #stocks #biotech #pharma #nasdaq #science
#RandD #research #biotech #biopharma
Allele Communications retweeted
This weeks Biotech Weekly report is out! Read the full report here: loom.ly/XOFx8-c
#capitalmarkets #analytics #stocks #biotech
#pharma #nasdaq #science
#RandD #research
Allele Communications retweeted
This weeks Biotech Weekly report is out! We are pleased to see our client @Genelux_Corp as the top performing Biotech IPO so far this year.
read the full report here loom.ly/XOFx8-c
#capitalmarkets #analytics #stocks #biotech
#pharma #nasdaq #science
#RandD #research
Allele Communications retweeted
ABVC is currently in clinical trials of several treatments with exciting herbal medicines, that go under US FDA standards and trials.
We have been able to show exceptional organic growth for our clients on their social media platforms. This growth is a result on creating high-quality, relevant content that resonates with target audiences.
#digitalmarketing #marketing #socialmedia
1
58
Allele Communications retweeted
Join @mattpillar at @BioProcessOL for an in-depth conversation with Dr. Michael Hufford, CEO of @LyGenesis as he speaks on the evolving industry of regenerative medicine and the advancements LyGenesis is making. Check out the video: loom.ly/xg3P2Hs
#CellTx #Bioreactor
Allele Communications retweeted
.@Genelux_Corp is redefining immuno-oncology.
$GNLX is a late clinical-stage biotechnology company focused on improving the lives of patients affected by difficult-to-treat solid tumors. #NasdaqListed #CancerResearch
Allele Communications retweeted
We are thrilled to announce that we will be ringing the opening bell at Nasdaq on March 29th 2023! #nasdaq #genelux #openingbell
loom.ly/BC4HfHI
Allele Communications retweeted
LyGenesis is currently enrolling patients with End Stage Liver Disease in a Phase 2 clinical study (NCT04496479). Visit our website for more information: loom.ly/grnU960.
#LymphNode #DrugDiscovery #EndStageLiverDisease #Biotech #OrganRegeneration #CellTherapy #Allogeneic
Welcoming Amazon to Pharma!
What does this mean for consumers, patients, doctors, and Pharma? Swipe and read more!
For more trending stories follow Allele Comms.
#Science #News #Biotech #Marketing #Communications #BioInformatics #Amazon
#Biotech #Allele #Pharma #DrugDiscovery
Promoting isn't worth anything unless you add value. At Allele, we add value for our clients. If you're interested in adding value to your business, email us [email protected]
#BrandAwareness #Biotech #Marketing #ScienceTwitter #BioInformatics #Pharma #DrugDiscovery
The uniqueness of life science and medical technology companies is not always easily understood, so their messaging must be. Let us help you!
#Science #Biotech #Marketing #Awareness #ScienceTwitter #BioInformatics
#Biotech #Allele #Analytics #Pharma #DrugDiscovery





















